Skip to search formSkip to main contentSkip to account menu

balsalazide

Known as: (e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid, (e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid, balsalazide [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

12 relations
Aminosalicylic AcidsBalsalazide disodiumBalsalazide disodium 750 MG Oral Capsule [Colazal]Drug Allergy

Broader (4)

Anti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsPhenylhydrazinesmesalamine

Narrower (3)

BX 661AColazalbalsalazine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
Background/Aims Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can… 
Review
2009
Review
2009
Granulomatous Pigmented Purpura: An Unusual Histological Variant
Pigmented purpuric dermatoses (PPDs) tend to vary clinically, yet share a similar histology. Granulomas are only rarely seen… 
Review
2008
Review
2008
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?
2006
2006
A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis.
Ulcerative colitis (UC) is a costly disease, especially if not properly treated. Epidemiologic studies have shown that many… 
Review
2006
Review
2006
Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature.
2005
2005
Comparative Analysis of the in Vitro Prosecretory Effects of Balsalazide, Sulfasalazine, Olsalazine, and Mesalamine in Rabbit Distal Ileum
Background: The aminosalicylates remain foundation therapy for mild‐to‐moderate ulcerative colitis. Pro‐drug 5‐aminosalicylic… 
Review
2004
Review
2004
The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
5-aminosalicylic acid agents are effective in the treatment of ulcerative colitis. Balsalazide, mesalamine, and olsalazine are… 
2004
2004
Patient‐led variable dosing with balsalazide as long‐term therapy for maintenance in ulcerative colitis: a 3‐year prospective observational study
Background : The patient‐centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be… 
2003
2003
A randomized controlled trial of a humanized Alpha4Beta7 antibody in Ulcerative Colitis (UC)
A randomized controlled trial of a humanized Alpha 4 Beta 7 antibody in Ulcerative Colitis (UC) 
Review
2002
Review
2002
Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
during esophageal variceal sclerotherapy with thrombin in cirrhotics. Am Surg 1991;57:222–5. 10. Williams SGJ, Peters RA, Westaby… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)